跳转至内容
Merck
CN
  • [Clinical, laboratory, and functional characteristic of patients with bronchial asthma and chronic obstructive pulmonary disease with disturbances of oxalic acid metabolism].

[Clinical, laboratory, and functional characteristic of patients with bronchial asthma and chronic obstructive pulmonary disease with disturbances of oxalic acid metabolism].

Klinicheskaia meditsina (2013-06-26)
L O Shaĭlieva, G B Fedoseev, M L Zorina, M A Petrova, V I Trofimov, A P Kakliugin
摘要

We studied the role of oxalate release through the airways as a potential injurious factor in the development of inflammation, bronchial obstruction and cough syndrome (respiratory oxalosis). Detection of oxalates in bronhcoalveolar lavage fluid and daily urine is the most valuable method for diagnostics of oxalates. Systemic effects, such as cholelithiasis, urolithiasis, and spinal osteochondrosis are characteristic clinical signs of respiratory oxalosis, besides purely respiratory symptoms.

材料
货号
品牌
产品描述

Sigma-Aldrich
乙二酸钠, ACS reagent, ≥99.5%
Sigma-Aldrich
草酸, 98%
Sigma-Aldrich
草酸, ReagentPlus®, ≥99%
Sigma-Aldrich
乙二酸钠, puriss. p.a., ACS reagent, ≥99.5% (RT)
Sigma-Aldrich
草酸, purified grade, 99.999% trace metals basis
Sigma-Aldrich
乙二酸钠, ≥99.99% trace metals basis
Sigma-Aldrich
乙二酸钠, BioXtra
Sigma-Aldrich
草酸, puriss. p.a., anhydrous, ≥99.0% (RT)
Supelco
乙二酸钠, reference material for titrimetry, certified by BAM, >99.5%
Supelco
草酸 溶液, 0.1 M (COOH)2 (0.2N), eluent concentrate for IC